Australia's most trusted
source of pharma news
Tuesday, 25 November 2025
Posted 24 November 2025 PM
With the last PBS listings of 2025 up for grabs there's been a rush of progress on reimbursement arrangements with 12 drugs on the cusp of winning a nod from the Minister.
Of those, nine are new listings including a new subcutaneous form of Roche's Ocrevus for adults with relapsing remitting multiple sclerosis.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.